Clinical Scorecard: Assessing the Impact of Multiparametric MRI on the Prediction of Extracapsular Extension in Prostate Cancer
At a Glance
Category
Detail
Condition
Clinically significant prostate cancer (csPCa) with extracapsular extension (ECE)
Key Mechanisms
Use of multiparametric MRI (mpMRI) with PI-RADS and ESUR scoring systems to predict ECE prior to radical prostatectomy
Target Population
Patients undergoing mpMRI before radical prostatectomy for prostate cancer
Care Setting
Urology and radiology departments in tertiary care centers
Key Highlights
mpMRI is the key diagnostic tool for clinically significant prostate cancer and is used for local staging to detect extracapsular extension.
PI-RADS v2 and ESUR-ECE scoring systems, along with subjective LIKERT assessments, are used to evaluate the likelihood of ECE on mpMRI.
Whole-mount histology from radical prostatectomy specimens serves as the reference standard for confirming ECE.
Guideline-Based Recommendations
Diagnosis
Perform 3-Tesla mpMRI with T2-weighted, diffusion-weighted imaging, ADC map, and dynamic contrast-enhanced sequences following PIRADS v1-v2 guidelines.
Use PI-RADS v2 scoring for lesion assessment and ESUR MRI scoring for extracapsular extension likelihood.
Apply LIKERT scales for subjective assessment of csPCa and ECE likelihood by experienced radiologists.
Management
Identify ECE presence preoperatively to balance oncological control with preservation of potency and continence during radical prostatectomy.
Incorporate mpMRI findings into surgical planning to optimize functional and oncological outcomes.
Monitoring & Follow-up
Ensure radiologists are blinded to clinical and histological data to reduce bias in mpMRI interpretation.
Assess inter-observer variability using intraclass correlation coefficients to maintain consistency in MRI scoring.
Risks
Delay MRI for 4–6 weeks post-biopsy to minimize hemorrhage artifacts that can affect image quality and interpretation.
Repeat MRI if substantial artifacts persist to ensure accurate staging.
Patient & Prescribing Data
126 patients undergoing mpMRI within 6 months prior to radical prostatectomy
mpMRI-based parameters combined with clinical and pathological data improve prediction of extracapsular extension, aiding in personalized surgical planning.
Clinical Best Practices
Follow standardized mpMRI acquisition protocols with pelvic phased-array coils and multiparametric sequences.
Use validated scoring systems (PI-RADS v2, ESUR-ECE) alongside subjective LIKERT assessments for comprehensive evaluation.
Incorporate histopathological correlation from whole-mount prostatectomy specimens as the diagnostic gold standard.
Apply logistic regression models to identify independent predictors of ECE for risk stratification.
Maintain adherence to ethical standards including patient data protection and institutional review board approvals.
by Francesco Sanguedolce, Alessandro Tedde, Luisa Granados, Jonathan Hernández, Jorge Robalino, Edgar Suquilanda, Matteo Tedde, Joan Palou, Alberto Breda
